Maneesrisajja T, Srikulawong K
Department of Orthopaedics, Nongkhai Hospital, Nong Khai, Thailand.
Malays Orthop J. 2024 Jul;18(2):63-70. doi: 10.5704/MOJ.2407.009.
The popular wound closure methods for carpal tunnel decompression (CTD) include non-absorbable and absorbable sutures which have comparable results in clinical outcomes. However, these wound closure methods are recommended to keep a wound dry which may limit some ADLs. We conducted a prospective randomized controlled trial that compares clinical outcomes and cost-effectiveness in a skin closure following CTD between absorbable sutures plus a 2-octyl cyanoacrylate tissue adhesive (2OCA) versus non-absorbable skin sutures plus a waterproof dressing (NSPWD).
We enrolled 120 patients undergoing CTD into two groups: 2OCA and NSPWD, with 60 patients in each group. Number of dressing changes, Quick DASH, pain VAS, cosmetic VAS, patient satisfaction VAS, and Hollander wound evaluation score, cost-effectiveness, and post-operative complications were collected at pre-operative period and two and six weeks post-operatively.
Slightly better patient satisfaction VAS (7.9 vs 7.2, p=0.018) and cosmetic VAS (8.0 vs 7.2, p=0.025) were observed in 2OCA at 2 weeks. Meanwhile, NSPWD revealed lesser times of dressing change (Median, mode, IQR: 0/0/0 vs 2/3/2, p<0.001). The total wound-related costs include dressing change and suture removal cost ($15.9 for 2OCA vs $19.2 for NSPWD, p=0.002) although an initial wound-related cost in 2OCA was higher ($15.7/case vs $7.9/case, p<0.001).
Our study revealed that the supplementary tissue adhesive to absorbable sutures following CTD could reduce total wound-related costs while clinical outcomes might not be considered clinically significant.
腕管减压术(CTD)常用的伤口闭合方法包括不可吸收缝线和可吸收缝线,二者临床效果相当。然而,这些伤口闭合方法都建议保持伤口干燥,这可能会限制一些日常生活活动(ADL)。我们进行了一项前瞻性随机对照试验,比较了可吸收缝线加2-辛基氰基丙烯酸酯组织粘合剂(2OCA)与不可吸收皮肤缝线加防水敷料(NSPWD)在CTD术后皮肤闭合方面的临床效果和成本效益。
我们将120例行CTD的患者分为两组:2OCA组和NSPWD组,每组60例。在术前、术后2周和6周收集换药次数、快速DASH量表、疼痛视觉模拟评分(VAS)、美容效果VAS、患者满意度VAS、霍兰德伤口评估评分、成本效益和术后并发症。
术后2周时,2OCA组患者满意度VAS略高于NSPWD组(7.9对7.2,p = 0.018),美容效果VAS也略高于NSPWD组(8.0对7.2,p = 0.025)。同时,NSPWD组换药次数较少(中位数、众数、四分位间距:0/0/0对2/3/2,p < 0.001)。尽管2OCA组的初始伤口相关成本较高(15.7美元/例对7.9美元/例,p < 0.001),但总的伤口相关成本包括换药和拆线成本2OCA组低于NSPWD组(15.9美元对19.2美元,p = 0.002)。
我们的研究表明,CTD术后在可吸收缝线上补充组织粘合剂可降低总的伤口相关成本,而临床效果在临床上可能不被认为具有显著意义。